健康体检市场机会、成长动力、产业趋势分析及预测（2025-2034）

2024 年全球健康体检市场价值为 574 亿美元，预计 2025 年至 2034 年期间的复合年增长率为 6.6%，这主要得益于癌症、糖尿病和心血管疾病等慢性疾病盛行率的不断上升。随着越来越多的人重视预防性护理，对常规医疗筛检的需求持续上升，以确保早期发现和改善治疗效果。随着诊断技术的进步，筛检变得更加容易，医疗保健提供者和保险公司正在强调早期诊断的重要性，进一步推动市场扩张。

随着主动健康管理意识的增强，定期检查正成为全球医疗保健策略不可或缺的一部分。保险公司越来越多地将预防性筛检纳入保险计划，鼓励个人定期进行医疗评估。政府和私人医疗保健提供者也正在发起宣传活动和健康计划，以促进预防性筛检。家庭诊断服务的便利性、远距医疗的日益普及以及人工智慧诊断工具的发展正在改变健康检查格局，使筛检更加高效和广泛可用。此外，雇主越来越多地支持员工健康和保健计划，从而促进了定期健康评估的参与。

市场按类型分为一般健康检查、专门健康检查、预防性健康检查以及常规和健康检查。其中，一般健康体检领域仍是市场成长的主导力量。预计该领域的复合年增长率为 6.5%，到 2034 年将达到 413 亿美元。常规医疗筛检可以早期发现疾病，降低严重健康併发症的风险，并有助于及时进行医疗干预。现在许多健康保险计划都包括定期检查，确保个人接受必要的评估以维持整体健康。

根据测试类型，健康体检市场包括全血细胞计数测试、血糖测试、肾功能测试、骨骼测试、电解质测试、肝功能测试、血脂测试、心臟生物标记、激素和维生素评估、肿瘤标记和其他诊断。全血球计数测试部分是市场扩张的关键推动因素，预计将以 6.2% 的复合年增长率成长，到 2034 年达到 241 亿美元。这些测试提供有关血球组成的重要见解，包括红血球和白血球计数以及血小板水平，使医疗保健提供者能够诊断贫血、感染和血液疾病等病症。血红素和血球容积比的测量也有助于评估营养状况，有助于识别缺铁和其他健康问题。

美国健康体检市场规模在 2024 年将达到 191 亿美元，预计在 2025 年至 2034 年期间的复合年增长率将达到 5.7%。糖尿病、高血压和心血管疾病等慢性病的盛行率不断上升，推动了频繁筛检的需求。此外，人口老化需要持续、全面的医疗评估，进一步刺激了预防性医疗保健服务的需求。随着医疗保健提供者和保险公司积极推动早期干预，美国的常规医疗评估变得越来越普遍。随着人们对主动健康管理的认识不断提高，健康体检市场将在未来十年持续扩张。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 人口筛检投资激增
    • 疾病盛行率不断上升
    • 老年人口增加
    • 数位科技的采用日益增多
  • 产业陷阱与挑战
    • 筛检成本高
    • 欠发达地区缺乏意识和适当的基础设施
• 成长潜力分析
• 监管格局
• 技术格局
• 报销场景
• 差距分析
• 波特的分析
• PESTEL分析
• 未来市场趋势
• 价值链分析
• 健康检查套餐概要
• 启动场景

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按类型，2021 - 2034 年

• 主要趋势
• 常规健康检查
• 常规健康检查
• 专业健康检查
• 预防性健康检查

第六章：市场估计与预测：按测试类型，2021 - 2034 年

• 主要趋势
• 全血球计数检查
• 血糖测试
• 电解质测试
• 血脂检测
• 荷尔蒙和维生素
• 肿瘤标记
• 肝功能检查
• 心臟生物标记
• 肾功能检查
• 骨轮廓测试
• 其他测试类型

第七章：市场估计与预测：依样本类型，2021 - 2034 年

• 主要趋势
• 血
• 尿
• 唾液
• 其他样本类型

第八章：市场估计与预测：按面板类型，2021 - 2034

• 主要趋势
• 多重测试面板
• 单项测试面板

第九章：市场估计与预测：按服务供应商，2021 - 2034 年

• 主要趋势
• 医院实验室
• 独立实验室
• 门诊护理中心
• 中央实验室
• 其他服务提供者

第十章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：公司简介

• ARUP Laboratories
• Cerba Healthcare
• eurofins
• Exact Sciences
• GRAIL
• INNOVA
• labcorp
• natera
• OPKO
• Q2 Solutions
• Quest Diagnostics
• Sonic Healthcare
• SYNLAB
• Trinity Biotech
• UNILABS

The Global Health Check-Up Market was valued at USD 57.4 billion in 2024 and is projected to expand at a CAGR of 6.6% from 2025 to 2034, driven by the increasing prevalence of chronic illnesses such as cancer, diabetes, and cardiovascular disorders. As more individuals prioritize preventive care, the demand for routine medical screenings continues to rise, ensuring early detection and improved treatment outcomes. With advancements in diagnostic technologies making screenings more accessible, healthcare providers and insurers are emphasizing the importance of early diagnosis, further propelling market expansion.

As the awareness of proactive health management gains traction, routine check-ups are becoming an integral part of healthcare strategies worldwide. Insurers are increasingly incorporating preventive screenings into coverage plans, encouraging individuals to undergo regular medical evaluations. Governments and private healthcare providers are also launching awareness campaigns and health programs to promote preventive screenings. The convenience of home-based diagnostic services, the growing penetration of telehealth, and the development of AI-driven diagnostic tools are transforming the health check-up landscape, making screenings more efficient and widely available. Additionally, increased employer initiatives supporting employee health and wellness programs are boosting participation in regular health assessments.

The market is segmented by type into general health check-ups, specialized health check-ups, preventive health check-ups, and routine and wellness health check-ups. Among these, the general health check-up segment remains a dominant force in market growth. This segment is expected to expand at a CAGR of 6.5%, reaching USD 41.3 billion by 2034. Routine medical screenings enable early disease detection, reducing the risk of severe health complications and facilitating timely medical interventions. Many health insurance plans now include regular check-ups, ensuring individuals receive essential evaluations to maintain their overall well-being.

Based on test type, the health check-up market comprises complete blood count tests, blood glucose tests, kidney function tests, bone profile tests, electrolyte tests, liver function tests, lipid profile tests, cardiac biomarkers, hormone and vitamin assessments, tumor markers, and other diagnostics. The complete blood count test segment is a key contributor to market expansion, projected to grow at a CAGR of 6.2% and reach USD 24.1 billion by 2034. These tests offer vital insights into blood cell composition, including red and white blood cell counts and platelet levels, enabling healthcare providers to diagnose conditions such as anemia, infections, and blood disorders. Hemoglobin and hematocrit measurements also help assess nutritional status, aiding in the identification of iron deficiency and other health concerns.

The US health check-up market, valued at USD 19.1 billion in 2024, is expected to grow at a CAGR of 5.7% between 2025 and 2034. The rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions is driving the need for frequent screenings. Additionally, the aging population requires consistent and comprehensive medical assessments, further fueling the demand for preventive healthcare services. With healthcare providers and insurers actively promoting early intervention, routine medical evaluations in the US are becoming increasingly common. As awareness surrounding proactive health management continues to grow, the health check-up market is poised for sustained expansion over the next decade.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Surging investments in population screening
    • 3.2.1.2 Increasing prevalence of diseases
    • 3.2.1.3 Rise in geriatric population
    • 3.2.1.4 Increasing adoption of digital technology
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with screening
    • 3.2.2.2 Lack of awareness and proper infrastructure in under-developed regions
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Reimbursement scenario
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Future market trends
• 3.11 Value chain analysis
• 3.12 Health check-up packages outline
• 3.13 Start-up scenario

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 General health check-up
• 5.3 Routine and wellness health check-up
• 5.4 Specialized health check-up
• 5.5 Preventive health check-up

Chapter 6 Market Estimates and Forecast, By Test Type, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Complete blood count test
• 6.3 Blood glucose test
• 6.4 Electrolyte test
• 6.5 Lipid profile test
• 6.6 Hormones & vitamins
• 6.7 Tumor markers
• 6.8 Liver function test
• 6.9 Cardiac biomarkers
• 6.10 Kidney function test
• 6.11 Bone profile test
• 6.12 Other test types

Chapter 7 Market Estimates and Forecast, By Sample Type, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Blood
• 7.3 Urine
• 7.4 Saliva
• 7.5 Other sample types

Chapter 8 Market Estimates and Forecast, By Panel Type, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Multi-test panels
• 8.3 Single-test panels

Chapter 9 Market Estimates and Forecast, By Service Provider, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Hospital-based laboratories
• 9.3 Standalone laboratories
• 9.4 Ambulatory care centers
• 9.5 Central laboratories
• 9.6 Other service providers

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 ARUP Laboratories
• 11.2 Cerba Healthcare
• 11.3 eurofins
• 11.4 Exact Sciences
• 11.5 GRAIL
• 11.6 INNOVA
• 11.7 labcorp
• 11.8 natera
• 11.9 OPKO
• 11.10 Q2 Solutions
• 11.11 Quest Diagnostics
• 11.12 Sonic Healthcare
• 11.13 SYNLAB
• 11.14 Trinity Biotech
• 11.15 UNILABS